Titre :
  • VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor.
Auteur : Vertongen, Pascale ; Camby, Isabelle ; Darro, Francis ; Kiss, Robert ; Robberecht, Patrick
Informations sur la publication : Neuropeptides, 30, 5, (page 491-496)
Statut de publication : Publié, 1996-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adenylate Cyclase -- metabolism
Brain Neoplasms -- pathology
Cell Cycle -- drug effects
Cell Division -- drug effects
DNA Replication -- drug effects
DNA, Neoplasm -- biosynthesis
Enzyme Activation -- drug effects
Glioblastoma -- pathology
Growth Inhibitors -- pharmacology
Humans
Neoplasm Proteins -- drug effects
Neoplasm Proteins -- physiology
Neuropeptides -- pharmacology
Pituitary Adenylate Cyclase-Activating Polypeptide
Polymerase Chain Reaction
RNA, Messenger -- biosynthesis
Receptors, Vasoactive Intestinal Peptide -- drug effects
Receptors, Vasoactive Intestinal Peptide -- physiology
Receptors, Vasoactive Intestinal Peptide, Type II
Tumor Cells, Cultured -- drug effects
Vasoactive Intestinal Peptide -- pharmacology
Note : Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0143-4179 
info:pii/S0143-4179(96)90015-3
info:pmid/8923513
VX-001639